While Micron and Dell have surged 260% in 2026 driven by AI server demand, five Russell 2000 small-cap stocks have each rallied over 400%. Four are AI supply chain plays (optical components, semiconductor testing, networking chips), while one is an unrelated healthcare company. Applied Optoelectronics leads at +473%, followed by Rackspace at +461%, Aehr Test Systems at +436%, agilon health at +404%, and MaxLinear at +398%.

Aehr Test Systems stock surged 16.2% following Vicor's unexpected raise in second-quarter revenue guidance. Vicor's strength in AI infrastructure power systems signals accelerating demand for data center solutions, which benefits Aehr's wafer-level burn-in test equipment business. Aehr recently received a $41 million order from a hyperscaler customer, bringing total orders to over $92 million for the second half of fiscal 2026, exceeding previous guidance.

Heather Fisher won an annual stock-picking contest with a 287% average return on three picks, primarily due to an 849% gain in Aehr Test Systems. However, Fisher sold most of her AEHR shares before the dramatic climb, missing out on significant gains. The contest had 42 participants, with 18 beating the S&P 500's 23.3% return.

Aehr Test Systems, a semiconductor testing equipment maker, has surged 327% year-to-date, significantly outperforming major chipmakers. The stock has risen 186% since March 30 following strong bookings and a record $41 million production order. However, the company remains unprofitable with a high price-to-sales ratio of 62, and analysts have a median price target of $67, suggesting 24% downside. While long-term prospects appear strong with anticipated 71% revenue growth in fiscal 2027, the stock may be overvalued in the near term.

Aehr Test Systems founder Rhea Posedel sold 17,719 shares worth approximately $1.77 million on April 22, 2026. While the insider sale is understandable given the stock's 1,076% surge in one year, driven by strong AI-related semiconductor testing demand and a record $41 million order, the company's valuation has become stretched with a price-to-sales ratio of 64. Revenue has actually declined year-over-year despite growing bookings, prompting analysts to suggest current shareholders should consider selling while new investors should wait for a price correction.

Aehr Test Systems director Fariba Danesh sold 8,000 shares (~$661K) on April 16, 2026, exercising expiring stock options. The sale is not necessarily bearish as it coincided with the company's announcement of a $41 million order from an AI hyperscaler customer. However, despite strong bookings driven by AI demand, recent revenue declined year-over-year, and the stock's lofty valuation (P/S ratio exceeding 55) suggests this is a better time to sell than buy.

Major tech developments this week include Amazon's acquisition of Globalstar for satellite communications capabilities, Snap's significant workforce reduction of 16%, and strong earnings from Taiwan Semiconductor Manufacturing. Other highlights include Uber's $10 billion robotaxi investment commitment, Aehr Test Systems' $41 million AI customer order, and various strategic partnerships across the tech and defense sectors.

The Russell 2000 small-cap index reached an intraday record high on Friday, capping a 13-day rally—its best run since 2020. The surge was driven by President Trump's announcement of a two-week military pause against Iran, which lowered oil prices and boosted expectations for Federal Reserve rate cuts. Regional banks, industrials, and biotech stocks have led the gains, with the iShares Russell 2000 ETF up 8.6% over two weeks compared to the S&P 500's 1.6% gain.

Aehr Test Systems has surged over 200% in 2026, becoming one of only five Russell 3000 stocks to achieve this return. The semiconductor testing equipment company announced a major customer win in silicon photonics on March 31, driving a 23% single-day gain. Despite missing Q3 revenue estimates, the company posted record bookings of $37.2 million and a record backlog of $50.9 million, signaling strong future growth in the AI infrastructure market. Craig Hallum upgraded the stock to Buy with a $68 price target.

Aehr Test Systems stock surged 25.7% on April 8, 2026, following strong fiscal Q3 earnings results and a broader market rally. While the company missed sales expectations slightly ($10.3M vs. $10.84M expected), it beat on earnings with a smaller-than-expected loss of $0.05 per share. The stock gained momentum from $37.2M in quarterly bookings and a growing backlog of $50.9M, with management guiding toward profitability in the current quarter. Year-to-date, AEHR is up 212%.

Aehr Test Systems stock surged 16.26% on April 6, 2026, driven by bullish market momentum following potential U.S.-Iran ceasefire negotiations, a recent contract win with a new customer announced on March 31, and investor anticipation ahead of the company's fiscal Q3 earnings report due after market close. The stock is up 158.1% year-to-date, though analysts caution that strong gains could lead to a pullback if earnings disappoint.

Aehr Test Systems stock rallied 30.6% this week after announcing its first silicon photonics customer order. The company received orders for wafer test and burn-in machines from a major networking products supplier for AI data centers. While the news is positive, the stock is already pricing in significant growth expectations, and Aehr's recent financials show declining revenue and negative profits as EV chip demand has weakened.